Sonoma Pharmaceuticals, Inc. (SNOA) insider have most recently took part in a trading activity. On Nov 29, 2017 Schutz James J, CEO bought 400 shares having total worth of $2,012 at the price of $5.03 per share, following the transaction a total of 15,829 shares owned by Schutz James J. Before this latest buy, Schutz James J purchased SNOA at 4 other times during the past twelve months, for a total investment of $16,659 at an average of $5.54 per share.
The stock has experienced a total of 2 insider trades in the past three months. These trades include 2 buy trades. Furthermore, over the past 12 months , the stock was traded 11 times by insiders. an employee of the company was the buyer in 11 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Sonoma Pharmaceuticals, Inc. (SNOA) traded up 1.8% on Nov 28, 2017, hitting $5.1. 15,750 shares of the company’s stock traded hands. Sonoma Pharmaceuticals, Inc. has a 52 week low of $3.66 and a 52 week high of $7.92. The company’s market cap is $0 million.
Sonoma Pharmaceuticals, Inc. (SNOA) last announced its earnings results on Nov 9, 2017. The company reported -0.67 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.63 by $0.04. The company had revenue of $4 million for the quarter, compared to the consensus estimate of $4 million. During the same quarter in the previous year, the company posted -0.46 earnings per share. The company’s revenue for the quarter was up 5% on a year-over-year basis.
|earnings per share||-0.67||-0.82|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018